Human Genetic Variation Alters Anthrax Toxin Sensitivity
Martchenko, Candille et al., PNAS
Researchers at Stanford University School of Medicine show that genetic variation affecting capillary morphogenesis gene 2, or CMG2, dramatically alters toxin sensitivity in humans. In its analysis, the team reports on "a CMG2 single-nucleotide polymorphism occurring frequently in African and European populations [that they found] independently altered toxin uptake." The group goes on to suggest "testing of genomically characterized human cell populations may offer a broadly useful strategy for elucidating effects of genetic variation on infectious disease susceptibility."
Illumina Outlines Software Rollout Plans for 2010; Works on Several Fronts to Ease Data Management
Illumina is preparing for the second meeting of its invite-only Genome Informatics Alliance and is continuing its IlluminaCompute initiative, which is an effort to make it easier for customers to set up and install an IT architecture for high-volume data management.
New to GenomeWeb? Register quickly here.